Yale University School of Medicine
333 Cedar Street, PO Box 208040
New Haven, Connecticut 06520
Yale Cancer Center is a Comprehensive Cancer Center designated by the National Cancer Institute (NCI). It has been a National Cancer Institute designated comprehensive cancer center for more than 30 years. Because Yale Cancer Center is a comprehensive cancer center, this means that not only does it focus on basic science research and clinical (patient-oriented) research, but it also focuses on control, prevention, and population sciences.
Yale Cancer Center is the only comprehensive cancer center in Southern New England and one of only 39 Centers in the nation. Comprehensive centers also serve their communities and regions, through education, information activities, and outreach. Comprehensive status is the highest possible ranking by the National Cancer Institute.
Yale Comprehensive Cancer Center, led by Dr. Richard L. Edelson and a staff of physicians, nurses, and scientists, has nearly a dozen multidisciplinary clinical programs including Thoracic Oncology; Leukemia, Lymphoma, and Melanoma; Head and Neck Cancers; Prostate and Urologic Cancers; Gastrointestinal Cancers, Gynecologic Oncology; Pediatric Oncology; Breast Cancer; Brain Tumor; Melanoma, and Genetic Counseling.
Patients with mesothelioma can expect comprehensive diagnosis, treatment, and counseling by a team of outstanding physicians who are also Professors, Directors, and Surgeons. The mesothelioma team includes: Peter Barrett, MD, MS, Assistant Professor Surgery; Roy Decker, MD, PhD, Assistant Professor, Therapeutic Radiology; Frank C. Detterbeck, MD, Professor Surgery and Associate Director of Clinical Affairs; Scott Gettinger, MD, Assistant Professor, Medical Oncology; Michael Kashgarian, MD, Professor Pathology, and Lynn D. Wilson, MD, MPH, Professor, Therapeutic Radiology.
Yale Comprehensive Cancer Center offers a wide variety of treatment plans and a multidisciplinary approach is used to evaluate and treat all cancer patients.
Comprehensive treatment plans may include chemotherapy, surgery or radiation. It may also include a combination of two or even all three treatments as well as conservative monitoring. In addition to comprehensive diagnosis, and treatment by a team of outstanding physicians, the medical professionals at Comprehensive Cancer Center also offer patients psychological support, supportive care, and long-term, follow-up care.
Yale Comprehensive Cancer Center is also a leader in clinical trials. At any given time, Yale Cancer Center has dozens of clinical trials available for cancer patients interested in the most advanced treatment options available. Currently, Yale Cancer Center has clinical trials available for the treatment of more than 15 diseases including: lung, melanoma, head and neck, leukemia and lymphoma, solid tumors, brain, breast, colorectal, kidney, gynecological, liver, prostate, and pancreas, to name a few.